Intuitive Surgical (NASDAQ:ISRG) SVP Sells 1,078 Shares of Company Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Patricia Wadors sold 1,078 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Trading Down 0.1%

NASDAQ:ISRG traded down $0.66 during mid-day trading on Monday, hitting $451.63. 2,916,696 shares of the company’s stock were exchanged, compared to its average volume of 2,433,892. The company has a 50 day simple moving average of $395.50 and a 200-day simple moving average of $408.83. The firm has a market capitalization of $156.55 billion, a P/E ratio of 54.61, a PEG ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the prior year, the business posted $2.40 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market commentators continue to view Intuitive Surgical as a strong growth company, citing durable demand for robotic-assisted surgery and potential for the stock to outperform the broader market. Intuitive Surgical Is an Incredible Growth Stock: 3 Reasons Why
• Positive Sentiment: Higher earnings estimates are providing a near-term bullish catalyst. The revisions suggest analysts are becoming more optimistic about ISRG’s financial outlook, potentially supporting further gains. Earnings Estimates Moving Higher for Intuitive Surgical
• Neutral Sentiment: ISRG is receiving elevated investor attention across financial websites, but the “trending stock” coverage is primarily informational rather than a new business or earnings announcement. Intuitive Surgical Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Commentary is also addressing whether Intuitive Surgical’s premium valuation is justified. This may keep investors selective even as the company’s long-term growth story remains intact. If Intuitive Surgical Stock Looks Expensive, You Need To Read This
• Negative Sentiment: Director Gary Guthart sold 20,095 shares for approximately $9.1 million, reducing his direct ownership by 1.64%. Because the sale was made under a pre-arranged Rule 10b5-1 plan, it may not reflect a change in the company’s outlook, but insider selling can still weigh on sentiment. SEC Insider Transaction Filing

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, September 20th. BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective on the stock. in a report on Thursday, July 30th. Finally, Stifel Nicolaus cut their price objective on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently modified their holdings of the company. Plato Investment Management Ltd acquired a new position in Intuitive Surgical during the second quarter worth $4,315,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Intuitive Surgical in the second quarter valued at $14,316,000. Hikari Power Ltd bought a new position in shares of Intuitive Surgical in the second quarter valued at $5,619,000. NewEdge Advisors LLC grew its holdings in shares of Intuitive Surgical by 19.1% during the second quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after buying an additional 8,142 shares during the last quarter. Finally, Nykredit A S acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $48,464,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.